Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dafna Gladman

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
RMD Open|March 21, 2018
4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritisDésirée van der Heijde, Atul Deodhar, Oliver FitzGerald, et al.
The Journal of Rheumatology|May 23, 2002
The rate and pattern of organ damage in late onset systemic lupus erythematosusPeter Maddison, Vernon Farewell, David Isenberg, et al.
Annals of the Rheumatic Diseases|May 3, 2012
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trialsSusan Manzi, Jorge Sánchez-Guerrero, Joan T Merrill, et al.
Plos Genetics|December 15, 2010
Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's diseasePatrick Danoy, Karena Pryce, Johanna Hadler, et al.
Rheumatology (Oxford, England)|March 14, 2023
Genetics of longitudinal kidney function in children and adults with systemic lupus erythematosusThai-Son Tang, Fangming Liao, Declan Webber, et al.
Arthritis and Rheumatism|April 9, 2005
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)Christian E Antoni, Arthur Kavanaugh, Bruce Kirkham, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|June 11, 2002
Counterbalancing patient demands with evidence: results from a pan-Canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosusPatricia L Dobkin, Deborah Da Costa, Lawrence Joseph, et al.
The Journal of Rheumatology|May 8, 2003
Group psychotherapy reduces illness intrusiveness in systemic lupus erythematosusSteven M Edworthy, Patricia L Dobkin, Ann E Clarke, et al.
Arthritis Research & Therapy|September 12, 2008
Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunityJoan Wither, Yong-chun Cai, Sooyeol Lim, et al.
The Journal of Rheumatology|September 28, 2007
The Canadian Rheumatology Association/ Spondyloarthritis Research Consortium of Canada treatment recommendations for the management of spondyloarthritis: a national multidisciplinary stakeholder projectWalter P Maksymowych, Dafna Gladman, Proton Rahman, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
RMD Open|March 21, 2018
4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritisDésirée van der Heijde, Atul Deodhar, Oliver FitzGerald, et al.
The Journal of Rheumatology|May 23, 2002
The rate and pattern of organ damage in late onset systemic lupus erythematosusPeter Maddison, Vernon Farewell, David Isenberg, et al.
Annals of the Rheumatic Diseases|May 3, 2012
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trialsSusan Manzi, Jorge Sánchez-Guerrero, Joan T Merrill, et al.
Plos Genetics|December 15, 2010
Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's diseasePatrick Danoy, Karena Pryce, Johanna Hadler, et al.
Rheumatology (Oxford, England)|March 14, 2023
Genetics of longitudinal kidney function in children and adults with systemic lupus erythematosusThai-Son Tang, Fangming Liao, Declan Webber, et al.
Arthritis and Rheumatism|April 9, 2005
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)Christian E Antoni, Arthur Kavanaugh, Bruce Kirkham, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|June 11, 2002
Counterbalancing patient demands with evidence: results from a pan-Canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosusPatricia L Dobkin, Deborah Da Costa, Lawrence Joseph, et al.
The Journal of Rheumatology|May 8, 2003
Group psychotherapy reduces illness intrusiveness in systemic lupus erythematosusSteven M Edworthy, Patricia L Dobkin, Ann E Clarke, et al.
Arthritis Research & Therapy|September 12, 2008
Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunityJoan Wither, Yong-chun Cai, Sooyeol Lim, et al.
The Journal of Rheumatology|September 28, 2007
The Canadian Rheumatology Association/ Spondyloarthritis Research Consortium of Canada treatment recommendations for the management of spondyloarthritis: a national multidisciplinary stakeholder projectWalter P Maksymowych, Dafna Gladman, Proton Rahman, et al.
Pageof 9